| Health Care Equipment & Supplies Industry | Healthcare Sector | Dave Hanson CEO | OTC PINK Exchange | 45684G508 CUSIP |
| US Country | 155 Employees | - Last Dividend | 22 Nov 2010 Last Split | - IPO Date |
Ingen Technologies, Inc. represents a dedicated player within the medical device sector, focusing its efforts on the development and innovation of home healthcare products specifically catered to the respiratory industry. With its operational base firmly established in Riverside, California, the company has been at the forefront of providing essential medical solutions since its inception in 1999. Ingen Technologies' mission revolves around enhancing the quality of life for individuals suffering from respiratory conditions, particularly chronic obstructive pulmonary disease (COPD), through the provision of advanced, user-friendly products. The company's commitment to research and development underscores its goal to address the evolving needs of patients requiring respiratory support in a home setting, thereby reflecting its contribution to public health and medical technology advancement in the United States.
This innovative oxygen flow meter is specifically designed by Ingen Technologies for patients requiring supplemental oxygen. Oxyview stands out for its precise monitoring capabilities, providing real-time feedback on the flow rate of oxygen being delivered. This transparency allows both patients and caregivers to ensure that the oxygen therapy is administered correctly, optimizing treatment efficacy and patient safety. The convenience and reliability of Oxyview make it an essential tool for managing chronic respiratory conditions at home.
Under the Ingen Technologies umbrella, the Smart Nasal Cannula represents a significant leap forward in nasal cannula technology. Trademarked for its uniqueness, this product is designed to deliver enhanced comfort and efficiency in oxygen therapy. By integrating smart features that adapt to the patient's breathing patterns, the Smart Nasal Cannula ensures a more personalized and effective oxygen delivery. Its design focuses on minimizing discomfort commonly associated with long-term use of nasal cannulas, thus improving patient compliance and overall quality of life for those suffering from COPD and other respiratory disorders.